Newer Pharmacotherapies Compared With Triptans for Migraine Treatment
The analysis included 64 randomized clinical trials with a total of 46,442 patients.
Pain Management
ASA: Standing Oral Acetaminophen Before Tonsillectomy Cuts IV Usage
Additional benefits include reducing variability and significant cost savings
Multimodel Anesthesia May Cut Opioid Usage After Head and Neck Cancer Surgery
Study authors analyzed the safety and efficacy of using MMA for patients undergoing head and neck surgery.
Adding Prednisone to Pain Regimens May Reduce Opioid Use After Oropharyngeal Surgery
Study authors assessed whether the addition of a prednisone taper could decrease opioid use in patients undergoing tonsillectomy, tonsillectomy and adenoidectomy, or expansion sphincter pharyngoplasty.
Narcotic Use Linked to More Complications After Pediatric Sinus Surgery
Multivariate analyses showed that the use of narcotic medications was significantly associated with greater 30-day postoperative complications.
DEA Warns of Fentanyl in Counterfeit Opioid Pills
This was the first public safety alert the DEA has issued in six years
Qulipta Approved for Preventive Treatment of Episodic Migraine
Results from ADVANCE showed statistically significantly greater decreases in mean monthly migraine days with atogepant compared with placebo.
Trudhesa Nasal Spray Now Available for Acute Treatment of Migraine
Trudhesa uses proprietary technology to deliver a lower dose (0.725mg per spray) of dihydroergotamine mesylate to the upper nasal space.
Migraine Management: How to Treat Patients With Vascular Disease
The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there’s no substantial evidence that they directly increase the risk for vascular events.
Traumatic Brain Injury Tied to Later Opioid Use, Misuse
History of TBI tied to 52 percent increased odds of prescription opioid use, 65 percent increased odds of prescription opioid misuse
